Treatment at home has become one of the most ambitious promises in modern UK healthcare. Behind this simple phrase sit two powerful ideas: NHS virtual wards and hospital-at-home programmes — …
January 2022
-
-
News
Referral-to-Diagnosis Delay Is Now One of the NHS’s Biggest Risks — And Why RTT Must Become the New Access Point for Fast, Safe Care (2025 Analysis)
Delays between referral and diagnosis are now one of the most serious and systemic patient-safety risks in the NHS elective and cancer pathways. While the NHS introduced the 28-Day Faster …
-
A scientific, health-economic analysis of why multinationals stall MedTech disruption—and how regulation, reimbursement, and system reform can rebuild an innovation engine. Medical devices shaped every major advance in modern medicine—from …
-
For years, Italy has carried a peculiar reputation in MedTech circles: admired for its surgeons, respected for its hospitals, but quietly avoided whenever the conversation turned to reimbursement.Executives would talk …
-
Learn how German hospitals use NUB 2026 to win InEK Status 1, negotiate innovation payments, and close DRG funding gaps with a practical step-by-step checklist. NUB 2026 Germany: 11 Steps …
-
How Scientific Abstracts and Reimbursement Really Connect in MedTech and Digital Health This article explains how scientific abstracts and reimbursement are linked in the MedTech, IVD, and digital health sectors. …
-
AI, biomarkers, and big data are transforming UK cancer care, rewriting NICE and NHS reimbursement. Here’s what it means for oncology innovators in 2025. A high-technology informatics revolution is reshaping …
-
When people talk about “NHS negligence”, they picture a surgeon in theatre, a midwife at the bedside, or a junior doctor on a night shift. They rarely picture the executive …